Chison Medical Technologies Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Chison Medical Technologies hat ein Gesamteigenkapital von CN¥1.4B und eine Gesamtverschuldung von CN¥0.0, wodurch sich der Verschuldungsgrad auf 0% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen CN¥1.6B bzw. CN¥210.9M. Chison Medical Technologies Das EBIT des Unternehmens beträgt CN¥76.2M, so dass der Zinsdeckungsgrad -2.4 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von CN¥1.1B.

Wichtige Informationen

Verhältnis von Schulden zu Eigenkapital

CN¥0

Verschuldung

Zinsdeckungsgrad	-2.4x
Bargeld	CN¥1.07b
Eigenkapital	CN¥1.38b
Gesamtverbindlichkeiten	CN¥210.95m
Gesamtvermögen	CN¥1.59b

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Chison Medical Technologies' (SHSE:688358) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Nov 06

The Market Lifts Chison Medical Technologies Co., Ltd. (SHSE:688358) Shares 39% But It Can Do More

Oct 08

Capital Allocation Trends At Chison Medical Technologies (SHSE:688358) Aren't Ideal

Sep 27

Chison Medical Technologies' (SHSE:688358) Solid Earnings May Rest On Weak Foundations

Apr 25

Further Upside For Chison Medical Technologies Co., Ltd. (SHSE:688358) Shares Could Introduce Price Risks After 27% Bounce

Mar 04

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: 688358Die kurzfristigen Aktiva des Unternehmens (CN¥1.4B) übersteigen seine kurzfristigen Passiva (CN¥200.4M).

Langfristige Verbindlichkeiten: 688358Die kurzfristigen Vermögenswerte des Unternehmens (CN¥1.4B) übersteigen seine langfristigen Verbindlichkeiten (CN¥10.6M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: 688358 ist schuldenfrei.

Schulden abbauen: 688358 hat in den letzten 5 Jahren keine Schulden gemacht.

Schuldendeckung: 688358 hat keine Schulden und muss daher nicht durch den operativer Cashflow gedeckt werden.

Zinsdeckung: 688358 hat keine Schulden, daher ist die Deckung der Zinszahlungen kein Problem.

Chison Medical Technologies Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

Chison Medical Technologies' (SHSE:688358) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Third quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.26 in 3Q 2023)

Investor sentiment deteriorates as stock falls 18%

The Market Lifts Chison Medical Technologies Co., Ltd. (SHSE:688358) Shares 39% But It Can Do More

New minor risk - Share price stability

Chison Medical Technologies Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Capital Allocation Trends At Chison Medical Technologies (SHSE:688358) Aren't Ideal

Investor sentiment improves as stock rises 19%

Second quarter 2024 earnings released: EPS: CN¥0.32 (vs CN¥0.53 in 2Q 2023)

Chison Medical Technologies Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024

Chison Medical Technologies' (SHSE:688358) Solid Earnings May Rest On Weak Foundations

First quarter 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.47 in 1Q 2023)

Chison Medical Technologies Co., Ltd., Annual General Meeting, May 10, 2024

Now 21% undervalued after recent price drop

Chison Medical Technologies Co., Ltd. to Report Q1, 2024 Results on Apr 19, 2024

Investor sentiment improves as stock rises 18%

Further Upside For Chison Medical Technologies Co., Ltd. (SHSE:688358) Shares Could Introduce Price Risks After 27% Bounce

Now 23% undervalued after recent price drop

Full year 2023 earnings: EPS and revenues miss analyst expectations

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 17%

Now 20% undervalued after recent price drop

Investor sentiment improves as stock rises 17%

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.44 in 3Q 2022)

Chison Medical Technologies Co., Ltd. (SHSE:688358) commences an Equity Buyback for CNY 20 million worth of its shares, under the authorization approved on September 12, 2023.

Second quarter 2023 earnings released: EPS: CN¥0.53 (vs CN¥0.46 in 2Q 2022)

Chison Medical Technologies Co., Ltd. to Report First Half, 2023 Results on Aug 29, 2023

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 31%

First quarter 2023 earnings released: EPS: CN¥0.47 (vs CN¥0.22 in 1Q 2022)

Third quarter 2022 earnings released: EPS: CN¥0.44 (vs CN¥0.27 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.46 (vs CN¥0.22 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First quarter 2022 earnings released: EPS: CN¥0.31 (vs CN¥0.28 in 1Q 2021)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.38 (vs CN¥0.33 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.31 (vs CN¥0.27 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.28 (vs CN¥0.22 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥1.32 (vs CN¥1.70 in FY 2019)

New 90-day low: CN¥49.00

New 90-day low: CN¥54.52

New 90-day low - CN¥61.94

New 90-day low - CN¥67.90

Chison Medical Technologies Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Entdecken Sie finanziell stabile Unternehmen